Augmedics launched new, FDA-cleared features and indications for its xvision Spine System. The update, which comes on the heels of the company’s 3,000th patient milestone, signifies xvision’s largest expansion since commercial launch and creates a technical foundation for future platform developments.
Included among the new features are artificial intelligence (AI) image enhancement functionality and new customizable views, which further expand xvision’s advanced visualization and customization capabilities. In addition, new cervical and iliosacral indications join existing thoracic, lumbar and sacral indications to expand xvision’s clearance to nearly the whole spine, allowing surgeons to benefit from the advantages of xvision navigation in posterior cervical and pelvic approaches, where anatomic and visualization challenges can significantly impact the procedure.
The company began rollout of the new updates to its user base, which spans 21 US states, in early January and estimates it will be largely complete by the end of the first quarter.
Augmedics launched new, FDA-cleared features and indications for its xvision Spine System. The update, which comes on the heels of the company’s 3,000th patient milestone, signifies xvision’s largest expansion since commercial launch and creates a technical foundation for future platform developments.
Included among the new features are...
Augmedics launched new, FDA-cleared features and indications for its xvision Spine System. The update, which comes on the heels of the company’s 3,000th patient milestone, signifies xvision’s largest expansion since commercial launch and creates a technical foundation for future platform developments.
Included among the new features are artificial intelligence (AI) image enhancement functionality and new customizable views, which further expand xvision’s advanced visualization and customization capabilities. In addition, new cervical and iliosacral indications join existing thoracic, lumbar and sacral indications to expand xvision’s clearance to nearly the whole spine, allowing surgeons to benefit from the advantages of xvision navigation in posterior cervical and pelvic approaches, where anatomic and visualization challenges can significantly impact the procedure.
The company began rollout of the new updates to its user base, which spans 21 US states, in early January and estimates it will be largely complete by the end of the first quarter.
Copy to clipboard 
